Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal

• The optimal antithrombotic regimen to be used in patients with AF and PCI or ACS is still debated. • Each of the six randomised controlled trials comparing double to triple therapy has limitations. • None was powered to assess differences between treatment arms in ischaemic event rates. • The cont...

詳細記述

保存先:
書誌詳細
出版年:Int J Cardiol Heart Vasc
主要な著者: Galli, Mattia, Andreotti, Felicita, D'Amario, Domenico, Vergallo, Rocco, Montone, Rocco A., Niccoli, Giampaolo, Crea, Filippo
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2020
主題:
Original Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7229495/
https://ncbi.nlm.nih.gov/pubmed/32435688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100524
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料